Amgen (AMGN) PT Raised to $375 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $417.57 --0%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 15
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 15
Join SI Premium – FREE
Jefferies analyst Michael Yee raised the price target on Amgen (NASDAQ: AMGN) to $375.00 (from $345.00) while maintaining a Buy rating.
You May Also Be Interested In
- Telenor ASA (TEL:NO) (TELNY) PT Lowered to NOK145 at JPMorgan
- Amgen (AMGN) PT Raised to $470 at UBS
- Amgen (AMGN) PT Raised to $430 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
